- Home
- ESAB vs TECH Comparison
ESAB vs TECH Comparison
Compare ESAB & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESAB
- TECH
- Stock Information
- Founded
- ESAB 1904
- TECH 1976
- Country
- ESAB United States
- TECH United States
- Employees
- ESAB N/A
- TECH N/A
- Industry
- ESAB Office Equipment/Supplies/Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESAB Industrials
- TECH Health Care
- Exchange
- ESAB Nasdaq
- TECH Nasdaq
- Market Cap
- ESAB 6.9B
- TECH 7.8B
- IPO Year
- ESAB N/A
- TECH 1989
- Fundamental
- Price
- ESAB $125.03
- TECH $47.32
- Analyst Decision
- ESAB Buy
- TECH Buy
- Analyst Count
- ESAB 8
- TECH 10
- Target Price
- ESAB $136.50
- TECH $73.44
- AVG Volume (30 Days)
- ESAB 261.6K
- TECH 2.2M
- Earning Date
- ESAB 05-01-2025
- TECH 05-07-2025
- Dividend Yield
- ESAB 0.32%
- TECH 0.68%
- EPS Growth
- ESAB 16.34
- TECH N/A
- EPS
- ESAB 4.43
- TECH 0.83
- Revenue
- ESAB $2,729,197,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- ESAB N/A
- TECH $7.16
- Revenue Next Year
- ESAB $4.79
- TECH $6.36
- P/E Ratio
- ESAB $28.33
- TECH $57.01
- Revenue Growth
- ESAB N/A
- TECH 4.72
- 52 Week Low
- ESAB $88.54
- TECH $46.01
- 52 Week High
- ESAB $135.97
- TECH $83.96
- Technical
- Relative Strength Index (RSI)
- ESAB 52.92
- TECH 41.23
- Support Level
- ESAB $127.61
- TECH $46.35
- Resistance Level
- ESAB $130.06
- TECH $49.92
- Average True Range (ATR)
- ESAB 2.75
- TECH 2.24
- MACD
- ESAB -0.15
- TECH 0.02
- Stochastic Oscillator
- ESAB 37.24
- TECH 15.21
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.